India: The Lipid Association of India (LAI) has released updated heart disease guidelines for Indian patients. The guideline was published online in the Journal of Clinical Lipidology on February 8, 2024.
In 2016, the LAI developed a cardiovascular risk assessment algorithm and defined low-density lipoprotein cholesterol (LDL-C) goals for preventing atherosclerotic cardiovascular disease (ASCVD) in Indians. The recent refinements in the role of several risk factors and subclinical atherosclerosis in predicting ASCVD risk necessitated updating the risk algorithm and treatment goals.
“Indians have a high prevalence of coronary artery disease associated with high mortality and morbidity as compared to the Western population despite basal LDL-C of approximately 10mg lower than the Western population.”
“This recently updated expert recommendation includes NAFLD, Metabolic syndrome in the high-risk atherosclerotic cardiovascular disease (ASCVD) group, air pollution, and fasting Triglyceride> 150mg as risk modifiers and ASCVD risk groups based on blood LDL-C and Non-HDL-C levels.”
For developing the guideline, the LAI core committee held twenty-one meetings and webinars from 2022 to 2023 with experts…
